Skip to main content
Clinical Trials/NCT03519776
NCT03519776
Completed
Not Applicable

Variation of Progesterone in IVF Cycles

ART Fertility Clinics LLC1 site in 1 country30 target enrollmentStarted: May 10, 2018Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
The variation of serum progesterone around the ovulation triggering in IVF-cycles

Overview

Brief Summary

to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering.

Detailed Description

The impact of the progesterone level at the end of the follicular phase in stimulated IVF/ICSI cycles and its effect on the pregnancy rate and oocyte quality is controversial, which arises from conflicting results in retrospective studies and meta-analyses. This study is assumed to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering. If variation is present, the impact of variation on the developing oocyte and embryo quality will be estimated by embryo quality indicators.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • patients 18-45 years
  • BMI 18-35 kg/m2
  • Menstrual cycle length 24-35 days
  • Stimulation with rFSH or hMG

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The variation of serum progesterone around the ovulation triggering in IVF-cycles

Time Frame: 6-8 months

the circadian secretion-pattern of progesterone during early follicular phase of normal cycling females

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials